Views & Analysis Why pharma companies need to upgrade their intelligence Pairing AI capabilities with human strengths can bring a competitive edge in this rapidly-changing world.
News AbbVie charts a new course for CGRPs in menstrual migraine AbbVie's Qulipta has become the first oral CGRP inhibitor to show efficacy in a phase 3 study involving women with menstrual migraine.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
